Lack in
biomarker characterization/validation strategies.
This also favors growth of the
biomarkers market in the near future.
the cancer
biomarkers market on the basis of cancer type is classified into breast, lung, colorectal, prostate, melanoma, leukemia, thyroid, bladder, non-hodgkin's lymphoma, kidney, and other cancers, such as cervical, multiple myeloma, and CNS, gastric, liver, pancreatic, oral cavity and pharynx, stomach, and ovarian cancers.
Over the past several years, there have been a number of serum and urine
biomarkers studied in an effort to find the one marker (or panel of markers) that will detect acute kidney injury in its early stages with high sensitivity and specificity.
Chapter 5,
biomarkers in health care, starts a pattern of organization characterized by paragraphs detailing individual
biomarkers by disease states and organ system.
An ideal
biomarker should be able to change the management of a patient
"There is a need for further studies using serum samples from new cohorts, a wider range of disease control subjects, as well as longitudinal studies to establish the usefulness of the four novel
biomarkers identified," they wrote.
"Using a proteomics approach, we have identified a panel of four blood-based
biomarkers that, when used in combination, can discriminate between healthy controls, asthmatics and individuals with COPD, and has the potential to be a valuable tool in the clinical diagnosis of respiratory disease," said Peter G.
Decision
Biomarkers is a privately-held life science tools company that has developed the next-generation technology for protein
biomarker analysis.
The
Biomarkers Consortium, Bethesda, Md., has launched a Web site to encourage researchers to submit
biomarker project concepts.